Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)

NCT06506084 is registered in ClinicalTrials.gov with FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS as lead sponsor.

NCT NCT06506084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06506084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)
Lead sponsor
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Phase
Observational
Overall status
Recruiting
Start date
September 8, 2022
Completion date
December 31, 2029
Enrollment
429 (estimated)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

polycythemia vera